Cargando…
Treatment of Diabetic Kidney Disease: Current and Future
Diabetic kidney disease (DKD) is the major cause of end-stage kidney disease. However, only renin-angiotensin system inhibitor with multidisciplinary treatments is effective for DKD. In 2019, sodium-glucose cotransporter 2 (SGLT2) inhibitor showed efficacy against DKD in Canagliflozin and Renal Even...
Autores principales: | Yamazaki, Tomotaka, Mimura, Imari, Tanaka, Tetsuhiro, Nangaku, Masaomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850867/ https://www.ncbi.nlm.nih.gov/pubmed/33508907 http://dx.doi.org/10.4093/dmj.2020.0217 |
Ejemplares similares
-
Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia
por: Yamazaki, Tomotaka, et al.
Publicado: (2023) -
Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes
por: Kawakami, Takahisa, et al.
Publicado: (2014) -
Chromatin remodeling factor, INO80, inhibits PMAIP1 in renal tubular cells via exchange of histone variant H2A.Z. for H2A
por: Miura, Rika, et al.
Publicado: (2023) -
Exploring molecular targets in diabetic kidney disease
por: Maruno, Sayako, et al.
Publicado: (2022) -
Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
por: Ishii, Taisuke, et al.
Publicado: (2021)